# FDA Inspection 1205324 - IntegoGen, LLC - February 03, 2023

Source: https://www.keypedia.com/records/fda_inspections/integogen-llc/c1316995-cbb2-4508-8d0f-88768af41d16
Source feed: FDA_Inspections

> FDA Inspection 1205324 for IntegoGen, LLC on February 03, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1205324
- Company Name: IntegoGen, LLC
- Inspection Date: 2023-02-03
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1205324 - 2023-02-03](https://www.keypedia.com/records/fda_inspections/integogen-llc/8c0f562c-2c67-4b9c-9788-cef9a1eb3785)
- [FDA Inspection 1205324 - 2023-02-03](https://www.keypedia.com/records/fda_inspections/integogen-llc/f23aa2ab-b902-4485-94a5-28a6a91f1e2c)
- [FDA Inspection 1027867 - 2017-06-12](https://www.keypedia.com/records/fda_inspections/integogen-llc/9b9236d1-f955-402c-a20a-0bb45c1da4c6)

Company: https://www.keypedia.com/companies/integogen-llc/5b5efcc6-d56a-4cc3-aa17-5bb211eb4582

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d